BioStem Technologies, Inc. (BSEM)
5.52
+0.02
(+0.36%)
USD |
OTCM |
Feb 12, 16:00
BioStem Technologies Free Cash Flow : 12.23M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Plus Therapeutics, Inc. | -15.78M |
| Iovance Biotherapeutics, Inc. | -351.82M |
| Protokinetix, Inc. | -0.2226M |
| GB Sciences, Inc. | -- |
| Travere Therapeutics, Inc. | -107.47M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.383M |
| Cash from Investing (Quarterly) | -1.168M |
| Cash from Financing (Quarterly) | -0.135M |
| Free Cash Flow Per Share (Quarterly) | -0.2066 |
| Free Cash Flow to Equity (Quarterly) | -4.599M |
| Free Cash Flow to Firm (Quarterly) | -4.801M |
| Free Cash Flow Yield | 9.96% |